Dual-Drug Backboned Polyprodrug with a Predefined Drug Combination for Synergistic Chemotherapy
journal contributionposted on 2021-02-26, 18:33 authored by Fangzhou Yu, Yalan Tu, Shiwei Luo, Xuan Xiao, Wang Yao, Maolin Jiang, Xinqing Jiang, Ruimeng Yang, Youyong Yuan
The codelivery of drugs at specific optimal ratios to cancer cells is vital for combination chemotherapy. However, most of the current strategies are unable to coordinate the loading and release of drug combinations to acquire precise and controllable synergistic ratios. In this work, we designed an innovative dual-drug backboned and reduction-sensitive polyprodrug PEG-P(MTO-ss-CUR) containing the anticancer drugs mitoxantrone (MTO) and curcumin (CUR) at an optimal synergistic ratio to reverse drug resistance. Due to synchronous drug activation and polymer backbone degradation, drug release at the predefined ratio with a synergistic anticancer effect was demonstrated by in vitro and in vivo experiments. Therefore, the dual-drug delivery system developed in this work provides a novel and efficient strategy for combination chemotherapy.